These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 27447744)
21. microRNA-495 promotes bladder cancer cell growth and invasion by targeting phosphatase and tensin homolog. Tan M; Mu X; Liu Z; Tao L; Wang J; Ge J; Qiu J Biochem Biophys Res Commun; 2017 Feb; 483(2):867-873. PubMed ID: 28069380 [TBL] [Abstract][Full Text] [Related]
22. miR-186 downregulates protein phosphatase PPM1B in bladder cancer and mediates G1-S phase transition. Yang J; Yuan D; Li J; Zheng S; Wang B Tumour Biol; 2016 Apr; 37(4):4331-41. PubMed ID: 26494000 [TBL] [Abstract][Full Text] [Related]
23. MicroRNA-155 promotes apoptosis in SKOV3, A2780, and primary cultured ovarian cancer cells. Chen W; Huang L; Hao C; Zeng W; Luo X; Li X; Zhou L; Jiang S; Chen Z; He Y Tumour Biol; 2016 Jul; 37(7):9289-99. PubMed ID: 26779627 [TBL] [Abstract][Full Text] [Related]
24. Sensitization of human bladder tumor cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis with a small molecule IAP antagonist. Griffith TS; Kucaba TA; O'Donnell MA; Burns J; Benetatos C; McKinlay MA; Condon S; Chunduru S Apoptosis; 2011 Jan; 16(1):13-26. PubMed ID: 20734142 [TBL] [Abstract][Full Text] [Related]
25. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737. Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352 [TBL] [Abstract][Full Text] [Related]
26. MCPIP1 Elicits a Therapeutic Effect on Cervical Cancer by Facilitating XIAP mRNA Decay via Its Endoribonuclease Activity. Luo J; He L; Guo Y; Wang J; Liu H; Li Z Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408613 [TBL] [Abstract][Full Text] [Related]
27. Tumor suppressive microRNA-1 mediated novel apoptosis pathways through direct inhibition of splicing factor serine/arginine-rich 9 (SRSF9/SRp30c) in bladder cancer. Yoshino H; Enokida H; Chiyomaru T; Tatarano S; Hidaka H; Yamasaki T; Gotannda T; Tachiwada T; Nohata N; Yamane T; Seki N; Nakagawa M Biochem Biophys Res Commun; 2012 Jan; 417(1):588-93. PubMed ID: 22178073 [TBL] [Abstract][Full Text] [Related]
28. Chetomin induces degradation of XIAP and enhances TRAIL sensitivity in urogenital cancer cells. Yano K; Horinaka M; Yoshida T; Yasuda T; Taniguchi H; Goda AE; Wakada M; Yoshikawa S; Nakamura T; Kawauchi A; Miki T; Sakai T Int J Oncol; 2011 Feb; 38(2):365-74. PubMed ID: 21165560 [TBL] [Abstract][Full Text] [Related]
29. Tumor suppressor functions of miR-133a in colorectal cancer. Dong Y; Zhao J; Wu CW; Zhang L; Liu X; Kang W; Leung WW; Zhang N; Chan FK; Sung JJ; Ng SS; Yu J Mol Cancer Res; 2013 Sep; 11(9):1051-60. PubMed ID: 23723074 [TBL] [Abstract][Full Text] [Related]
30. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma. Ma JJ; Chen BL; Xin XY Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):222-6. PubMed ID: 19758744 [TBL] [Abstract][Full Text] [Related]
31. miR-21 regulates N-methyl-N-nitro-N'-nitrosoguanidine-induced gastric tumorigenesis by targeting FASLG and BTG2. Yang Q; Xu E; Dai J; Wu J; Zhang S; Peng B; Jiang Y Toxicol Lett; 2014 Aug; 228(3):147-56. PubMed ID: 24821435 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of MDM2 homodimerization by XIAP IRES stabilizes MDM2, influencing cancer cell survival. Liu T; Zhang H; Xiong J; Yi S; Gu L; Zhou M Mol Cancer; 2015 Mar; 14():65. PubMed ID: 25888903 [TBL] [Abstract][Full Text] [Related]
33. MicroRNA-155 promotes bladder cancer growth by repressing the tumor suppressor DMTF1. Peng Y; Dong W; Lin TX; Zhong GZ; Liao B; Wang B; Gu P; Huang L; Xie Y; Lu FD; Chen X; Xie WB; He W; Wu SX; Huang J Oncotarget; 2015 Jun; 6(18):16043-58. PubMed ID: 25965824 [TBL] [Abstract][Full Text] [Related]
34. XIAP inhibitor Embelin inhibits bladder cancer survival and invasion in vitro. Fu X; Pang X; Qi H; Chen S; Li Y; Tan W Clin Transl Oncol; 2016 Mar; 18(3):277-82. PubMed ID: 26209051 [TBL] [Abstract][Full Text] [Related]
35. miR-27a regulates the sensitivity of breast cancer cells to cisplatin treatment via BAK-SMAC/DIABLO-XIAP axis. Zhou S; Huang Q; Zheng S; Lin K; You J; Zhang X Tumour Biol; 2016 May; 37(5):6837-45. PubMed ID: 26662313 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway. Chen S; Chen X; Xiu YL; Sun KX; Zhao Y PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027 [TBL] [Abstract][Full Text] [Related]
37. The tumor-suppressor gene Nkx2.8 suppresses bladder cancer proliferation through upregulation of FOXO3a and inhibition of the MEK/ERK signaling pathway. Yu C; Zhang Z; Liao W; Zhao X; Liu L; Wu Y; Liu Z; Li Y; Zhong Y; Chen K; Li J; Zhou F; Song L Carcinogenesis; 2012 Mar; 33(3):678-86. PubMed ID: 22223847 [TBL] [Abstract][Full Text] [Related]
38. miR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling. Guo Y; Ying L; Tian Y; Yang P; Zhu Y; Wang Z; Qiu F; Lin J FEBS J; 2013 Sep; 280(18):4531-8. PubMed ID: 23815091 [TBL] [Abstract][Full Text] [Related]
39. Targeting of X-linked inhibitor of apoptosis protein and PI3-kinase/AKT signaling by embelin suppresses growth of leukemic cells. Prabhu KS; Siveen KS; Kuttikrishnan S; Iskandarani A; Tsakou M; Achkar IW; Therachiyil L; Krishnankutty R; Parray A; Kulinski M; Merhi M; Dermime S; Mohammad RM; Uddin S PLoS One; 2017; 12(7):e0180895. PubMed ID: 28704451 [TBL] [Abstract][Full Text] [Related]
40. MiR-618 inhibits anaplastic thyroid cancer by repressing XIAP in one ATC cell line. Cheng Q; Zhang X; Xu X; Lu X Ann Endocrinol (Paris); 2014 Sep; 75(4):187-93. PubMed ID: 25145559 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]